title: Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685.
abstract: SK&F 105685 (N,N-Dimethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2- propanamine dihydrochloride) is a novel azaspirane which has therapeutic activity in rat models of autoimmune disease. In this study, we have demonstrated that SK&F 105685 is a potent inducer of non-specific suppressor cells (SC). Oral administration of 15-30 mg/kg/day results in the generation of SC in the spleen, lymph nodes and bone marrow, but not the thymus of Lewis rats. Splenic SC suppress Con-A-induced proliferation in co-culture assays at effector-responder ratios of 1:1 to 1:64. SC are radiation resistant (2000 R), non-T, non-B cells, partially adherent to plastic surfaces and are enriched in a 1.07 g/ml fraction of a Percoll density gradient. Their activity is increased, rather than ablated, by indomethacin. No definitive changes in Ig+, OX-19+, OX-8+, W3/25+ or asialo GM1+ cells could be detected in the spleens of treated rats compared to control untreated animals. Elevated levels of both radiation-sensitive and radiation-resistant suppressor cells were found in the bone marrow of treated rats in addition to the radiosensitive SC normally present in this tissue.
authors: Department of Immunology, Smith Kline Beecham Pharmaceuticals, King of Prussia, PA 19406.
authors: A M
authors: AM
authors: Badger
authors: A G
authors: AG
authors: King
authors: J E
authors: JE
authors: Talmadge
authors: D A
authors: DA
authors: Schwartz
authors: D H
authors: DH
authors: Picker
authors: C K
authors: CK
authors: Mirabelli
authors: N
authors: N
authors: Hanna
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000284:Administration, Oral; D000818:Animals; D002469:Cell Separation; D008213:Lymphocyte Activation / Q000187:drug effects; D008221:Lymphoid Tissue / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D008297:Male; D011836:Radiation Tolerance; D051381:Rats; D011917:Rats, Inbred Lew; D013141:Spiro Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000276:immunology / Q000528:radiation effects
chemical_list: D000276:Adjuvants, Immunologic; D013141:Spiro Compounds; C062162:SK&F 105685